undefined
EUTM file information

018679112


March 29, 2022

Trademark Summary

The trademark application was filed by Avidity Biosciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 16, 2022, and it was registered by office on September 23, 2022 without any oppositions.

The application was filed in Danish (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on February 28, 2024.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies
    2. Chemical preparations for medical purposes
    3. Oligonucleotides, polynucleotides, synthetic genes for medical purposes
    4. Oligonucleotide sets for DNA-arrays
    5. Gene library, genetic-engineering material, including genes, fragments thereof and their combinations all these products in relation with medical purposes.
  • The mark was filed in class 42 with following description of goods:
    1. Conducting clinical trials in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy
    2. Conducting clinical trials in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
    3. Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
    4. Medical and scientific research, namely, conducting clinical trials for oligonucleotide-based therapeutics
    5. Scientific and industrial research
    6. Carrying out of chemical, biological or molecular biological methods
    7. Sequencing of DNA, analyzing of biological data, creating of gene libraries
    8. Carrying out of methods for processing of oligonucleotides
    9. Creating of software for controlling chemical or biological methods, creating of software for analyzing of biological data, creating of software for administrating chemical or biological substances, development, design and production of DNA-chips, peptide-chips, DNA-microarrays, peptide-microarrays, biochips
    10. Computer programming in the field of scientific research
    11. Experts reports for scientific, medical or industrial purposes of scientists and engineers
    12. Technical project studies
    13. Professional consultancy in the field of scientific research and treatments.